AbbVie bids $63 billion to acquire Allergan

North Chicago-based AbbVie has presented a $63-billion, cash-and-stock offering to shareholders of Ireland-based Allergan, representing a 45% premium over the latter’s June 24 stock price. AbbVie expects the completion of the acquisition to take the rest of this year. In […]

Read More

Book Review: Bottle of Lies

There has been a steady drip, drip, drip of reports and regulatory actions for generic drug quality in recent years, with much of the focus on the dramatic growth of the Indian pharmaceutical industry since the turn of the century. […]

Read More

John Gray hangs up his spurs as head of HDA

As president and CEO of the Healthcare Distribution Alliance since 2004 (known as the Healthcare Distribution Management Assn. since 2016), John Gray oversaw the conversion of the association to a primary-distributor-only group in the mid-2000s, led industry involvement in the […]

Read More